ARC
CODX

Advisor Resource Council’s Co-Diagnostics CODX Stock Holding History

Advisor Resource Council’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,088
Closed -$351K – 213
2022
Q2 		$351K Sell
2,088
-6,691
-76% -$1.02M 0.03% 355
2022
Q1 		$1.63M Sell
8,779
-1,102
-11% -$228K 0.49% 58
2021
Q4 		$2.65M Hold
9,881
– – 0.21% 99
2021
Q3 		$2.88M Buy
9,881
+667
+7% +$195K 0.87% 27
2021
Q2 		$2.28M Buy
+9,214
New +$2.37M 0.24% 91

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Advisor Resource Council's CODX Position: Q3 2022 in Review

Advisor Resource Council sold out of Co-Diagnostics (CODX) in Q3 2022, closing a stake of 2,088 shares — an estimated $351K sold.

Advisor Resource Council first reported a position in CODX in Q2 2021 and held it in 5 quarters. The position peaked at $2.88M in Q3 2021. 65 funds tracked by Wall St. Rank hold CODX as of Q3 2022.

  • Advisor Resource Council reported no remaining Co-Diagnostics position as of Q3 2022 after selling out during the quarter.
  • Advisor Resource Council sold 2,088 Co-Diagnostics shares in Q3 2022, an estimated $351K.
  • Advisor Resource Council first reported a position in Co-Diagnostics in Q2 2021 and held it in 5 quarters.
  • Advisor Resource Council's Co-Diagnostics position peaked at $2.88M in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2022.

Based on Advisor Resource Council's 13F filing for Q3 2022, filed 26 Oct 2022.